ABSTRACT
INTRODUCTION
In recent years, the use of third-generation cephalosporin (TGC) has led to the promotion of a selection of β-lactamase producer bacteria that performs a hydrolysis of TGC, especially the oxyimino-cephalosporins [1, 31] .These enzymes, capable of hydrolyzing the newer β-lactams, are referred to as extended-spectrum β-lactamases (ESBLs) [1, 2] . At hospital sites, ESBL K. pneumoniaeresistant isolates are becoming an emerging public health concern. The ESBL-producing isolates of Klebsiella. spp. (ESBL-K) have been involved in several outbreaks of nosocomial infections throughout Asia [ 3] , including Iran [4, 32 ] , the United States of America [5] , the Far East, and Europe [ 6] . Recently, blaCTX-M-related genes have appeared as the leading type of ESBLs in many parts of the world, including Asia, Europe [7] , the United States [8] , and South America [9] . On the basis of amino acid sequence, more than 60 variants that include CTX-M-45, CTX-M-25, CTX-M-9, CTXM-8, CTX-M-2, and CTX-M-1 [10] . These Klebsiella ESBL-producing isolates may be have. TEM, SHV, and CTX-M-β-lactamases [10] . ESBL-K strains are prevalent in Tehran hospitals, but relatively little data are available about β-lactamase genes. Moreover, carbapenem antibiotics are useful for treating infections caused by ESBL-producing gram-negative bacteria. In recent years, carbapenem resistance is considered one of the most significant challenges in the treatment of patients in hospitals. The rapid spread of the carbapenem-hydrolyzing β-lactamase KPC between Klebsiella isolates CR in the Tehran region has turned alarming. Treatment of infection caused by this pathogen has become a matter of significant challenge in hospitals in Iran due to its high levels of resistance to virtually all classes of antibiotics. Therefore, the identification of KPC resistance is important for the appropriate choice of antibiotic treatment in addition to infection control measures to thwart the distribution of resistant Klebsiella strains in hospital settings. The aim of this study was to determine the prevalence of ESBL subtypes and important carbapenem resistance genes (KPC/OXA-48/NDM1) among Klebsiella cultured from patients at a hospital in Tehran, Iran.
MATERIALS AND METHODS

Bacterial strains
The present work is a descriptive cross-sectional study carried out from August 2013 to July 2016. 
Modified Hodge Testing (MHT)
The confirmation of carbapenemase activity was done using an MHT as previously stated [11] . The K. pneumonia, a positive control MHT Positive Klebsiella pneumoniae ATCC1705, and MHT Negative Klebsiella pneumoniae ATCC1706 were used as a positive control. In plates, the presence of a distorted or clover leaf-shaped inhibition zone was considered as positive for carbapenemase-producing isolates, as recommended by the document M100-S24 of the Clinical and Laboratory Standards Institute methods [11, 12] .
Carbapenem Inactivation Method Test (CIM)
The CIM was performed as previously stated with brief changes [3] . The isolates were cultured on MHA (Mueller-Hinton agar) plates and a full 12-µl inoculation loop of each strain was immersed in 420 µl of sterile distilled water, and an active susceptibility meropenem disc (MEM) was homogenized in the solution. After two hours incubation at 35°C, the disk was detached and placed on an MHA plate inoculated with a suspension of OD595 1.25 (correlates with a McFarland value of 0.5) standard of susceptible E. coli indicator strain ATCC 25922 with a sterile cotton swab. Finally, incubation of the plate was done at 35°C for 24 h. The results of the test were surveyed after overnight incubation: The inhibition zone in plates around each disk was measured. Plates with inhibition circles <10 mm in diameter were considered to indicate CIM positivity [13] [14] [15] .
Polymerase chain reaction amplification (PCR) and DNA sequence analysis
The total genomic DNA from the clinical isolates was extracted by the boiling method: four colonies of each isolate in 600 ml of distilled water for 12 min. and centrifuged at 11,000 rpm for 12 min. The supernatant was used for the PCR test. PCR amplification was performed using the specific primers for the blaKPC family, Uni-KPC-F (5'-ATGTCACTGTATCGCCGTCT-3') and Uni-KPC-R (5'-TTACTGCCCGTTGACGCCC-3') genes as previously described (16) . PCR amplification and primers for the detection of blaCTX-M, blaTEM, blaSHV, blaKPC, blaOXA-48-like, blaNDM, blaVIM, and blaIMP genes was carried out as previously described by Hosseinzadeh et al. and Fursova et al [17, 18, 33, 34] . The sequences were aligned and compared using the online BLAST software, (BLAST http: //www.ncbi.nlm. nih.gov).
RESULTS
Of the eight available antibiotics, the most effective was colisitin (100% of the strains were susceptible). The results of the antimicrobial susceptibility test are shown in Table 1 . Distribution of collected samples included BAL 22 (40.7%), Wound 5 (9.2%), Urine 9 (16.6%), Blood 9 (16.6%), Plural 3 (5.5%), Sputum 4 (7.4%), Abscess 1 (1.8%), and Abdominal 1 (1.8%) (Fig.4) . Klebsiella spp. was detected in 25.9% (n=14) isolates in the <50 years age group and 70.0% (40) isolates in the ≥ 50 years age group, but this difference was not statistically significant (P > 0.05). Thirty-one (57.4%) males and 23 (42.5%) females were infected with Klebsiella (Fig.3) . Isolates with positive results of the carbapenem inactivation method test (CIM) and modified Hodge testing (MHT) were considered carbapenem-resistant. MIC results for five antibiotics Cp, IMP, MP, CAZ, and CRO showed a high level of resistance (MIC≥4). The phenotypic confirmatory test showed that among the 54 isolates, 54 (100%) were ESBL producers (14) . The PCR test of the ESBLproducing isolates showed that TEM 24 (44.4%) isolates were positive for the blaTEM gene, 40 (80.1%) positive for the blaCTX-M groups, and 30 (55.6%) isolates had the blaSHV gene. Moreover, the SHV types were characterized as SHV-27, SHV-11, and SHV-1. Coexistence of multiple gene-encoding ESBLs identified among the isolates included blaTEM, CTX-M blaSHV, and blaTEM, SHV (Fig. 1) . Our PCR data demonstrated that among the K. pneumoniae clinical strains, blaCTX-M15 23 (42.6%) gene were the most prevalent in our hospital followed by group genes blaCTX-M2 11 (20.38%) and blaCTX-M3 10 (18.51). The distribution of CTX-M groups revealed that blaCTX-M-15 was the dominant subtype. In the present study, all 44 CTX-M-harboring Klebsiella isolates studied were found to be resistant to cefotaxime and ceftazidime by using the standard disk diffusion method and E-test MIC, according to the CLSI guidelines. Of the 55 high level resistance Klebsiella included in the study, 40 (74.0%) were found, by the PCR reaction test, to carry a carbapenemase-encoding gene, and all PCRpositives (100%) were shown to produce carbapenemase by the CIM except one isolate ( Table  2) . The results of MHT in all ESBL isolates were positive. BlaNDM1, blaOXA-48 and blaKPC were identified in carbapenem-resistant isolates, 22 (%40.7), 10 (%18.5), and 7 (%12.9) respectively. causing concern over the control of hospital infections [14] . In this situation, with increasing high-level resistant isolates, early detection of CPK strains is critical. A study by van der Zwaluw et al. [15] showed that CIM is a new method having high specificity and sensitivity for detecting carbapenemase producers. The modified Hodge test and CIM methods were used in our research. Results demonstrated that, of the 54 isolates, only one was CIM-negative (2.0%), while all the other isolates emerged positive in the modified Hodge test. The application of the CIM test for the detection of carbapenem-resistant isolates in our study showed it is capable of detecting carbapenemase production. Using PCR, 40 (74%) of these isolates were found to contain a carbapenemaseencoding gene. These results of CIM are consistent with other findings stated by some other researches [14, [15] [16] [17] [18] [19] . With respect to our research, CIM for the first time in Iran was found to be very efficient and low-cost in the recognition of carbapenemaseproducing K. pneumoniae isolates. In the clinical setting, the distribution of ESBL-producing K. pneumoniae was considered an important therapeutic and epidemiological concern. During the past decade, CTX-M.15, CTX-M-14, and CTX-M-2 have been the most prevalent CTX-M enzyme in different European countries and Iran [20, 21] . The present study further showed that the CTX-M1 group had a high (92.7%) prevalence in clinical ESBL-producing isolates, and the most common subtype was CTX-M15. In a study 
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CIM. Phenotype OXA-48-positive in KPC strains has been stated in several regions, including France, Russia, Turkey, Saudi Arabia, Taiwan, and China, and can be a serious concern in hospital settings [17] . In our study, a small number of carbapenem-resistant isolates lacked the targeted genes. The reasons for this may be the reduced permeability of the outer membrane, presence of other genes, AmpC betalactamases, and an extended-spectrum betalactamases (ESBLs) [17, 28, 29] . In the present study, we detected the blaKPC gene in just seven (12.9) CR isolates that were susceptible to tigecycline and polymyxin B. Similar to our findings, other KPCharboring isolates revealed a resistance to the majority of antimicrobial agents [30] . In summary, we have described for the first time the high coexistence of blaKPC/NDM1/OXA-48 and blaCTX-M -producing Klebsiella. spp. in KP isolates in Tehran, and characterized the CIM method as being efficient for the detection of CRK strains in hospital settings in Iran.
Conclusion:
Our research confirmed that the CIM test is practicable in our laboratory and has a high capability of fast detection of CRK. We are faced with the emergence of CTX-M, OXA-48, KPC, and NDM1 harboring CRK strains in our hospitals. All isolates showed a high level of resistance (ESBLpositive/carbapenem-positive), indicating a situation that was considered to pose a future threat and highlighting the necessity of further surveillance in a hospital setting. So, with the rapid emergence of multi-drug resistance isolates over time, the prevention of the spread of the CPK and the initiation of appropriate antimicrobial therapy will be a matter of serious concern in our clinical settings.
